Patent · US Active

Substituted imidazoquinolines as agonists of TLR7

US11987569B2 · kind B2 · utility

0Cited by

1References

16Claims

0Family size

Assignee

BIONTECH SE · DE

Inventor

Christophe Henry · Munich, DE

Key dates

Filing date	Feb 10, 2022
Grant date	May 21, 2024
Priority date	—
Expiry date	Feb 26, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.